These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12441327)

  • 21. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
    Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
    Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China.
    Wang H; Liu J; Dilimulati ; Li L; Ren Z; Wen H; Wang X
    Virol J; 2011 Dec; 8():539. PubMed ID: 22168313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel.
    Iscovich J; Fischbein A; Fisher-Fischbein J; Freedman LS; Eng SM; Boffetta P; Vudovich A; Glasman C; Goldschmidt R; Livingston M; Heger-Maslansky B; Brennan P; Moore PS
    Anticancer Res; 2000; 20(3B):2119-22. PubMed ID: 10928163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
    Brown EE; Fallin MD; Goedert JJ; Chen R; Whitby D; Foster CB; Lauria C; Alberg AJ; Messina A; Montella M; Rezza G; Vitale F; Chanock SJ;
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):633-7. PubMed ID: 15767342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China.
    Ouyang X; Zeng Y; Fu B; Wang X; Chen W; Fang Y; Luo M; Wang L
    Viruses; 2014 Nov; 6(12):4800-10. PubMed ID: 25431948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma.
    Ngalamika O; Munsaka S
    J Immunol Res; 2020; 2020():8852221. PubMed ID: 33294468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.
    Knowles DM; Cesarman E
    Ann Oncol; 1997; 8 Suppl 2():123-9. PubMed ID: 9209655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
    Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
    Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human herpesvirus 8 and Kaposi's sarcoma.
    Dictor M
    Semin Cutan Med Surg; 1997 Sep; 16(3):181-7. PubMed ID: 9300629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
    Marcelin AG; Gorin I; Morand P; Ait-Arkoub Z; Deleuze J; Morini JP; Calvez V; Dupin N
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):704-8. PubMed ID: 15307914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
    Davis DA; Humphrey RW; Newcomb FM; O'Brien TR; Goedert JJ; Straus SE; Yarchoan R
    J Infect Dis; 1997 May; 175(5):1071-9. PubMed ID: 9129068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.
    Corbellino M; Poirel L; Bestetti G; Pizzuto M; Aubin JT; Capra M; Bifulco C; Berti E; Agut H; Rizzardini G; Galli M; Parravicini C
    AIDS Res Hum Retroviruses; 1996 May; 12(8):651-7. PubMed ID: 8744575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.
    Olp LN; Minhas V; Gondwe C; Kankasa C; Wojcicki J; Mitchell C; West JT; Wood C
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26185193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.